6127 Stock Overview
Provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Joinn Laboratories(China)Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.40 |
| 52 Week High | CN¥14.62 |
| 52 Week Low | CN¥6.31 |
| Beta | 0.66 |
| 11 Month Change | 1.18% |
| 3 Month Change | 35.84% |
| 1 Year Change | -34.17% |
| 33 Year Change | -80.83% |
| 5 Year Change | n/a |
| Change since IPO | -81.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6127 | HK Life Sciences | HK Market | |
|---|---|---|---|
| 7D | 2.0% | -4.1% | 1.6% |
| 1Y | -34.2% | -57.6% | 10.1% |
Return vs Industry: 6127 exceeded the Hong Kong Life Sciences industry which returned -57.6% over the past year.
Return vs Market: 6127 underperformed the Hong Kong Market which returned 10.1% over the past year.
Price Volatility
| 6127 volatility | |
|---|---|
| 6127 Average Weekly Movement | 15.1% |
| Life Sciences Industry Average Movement | 12.8% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 6127's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 6127's weekly volatility has increased from 10% to 15% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 2,585 | Dapeng Gao | www.joinn-lab.com |
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models.
Joinn Laboratories(China)Co.,Ltd. Fundamentals Summary
| 6127 fundamental statistics | |
|---|---|
| Market cap | HK$12.93b |
| Earnings (TTM) | -HK$980.45k |
| Revenue (TTM) | HK$2.28b |
6.1x
P/S Ratio9,999x
P/E RatioIs 6127 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6127 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.12b |
| Cost of Revenue | CN¥1.47b |
| Gross Profit | CN¥653.83m |
| Other Expenses | CN¥654.75m |
| Earnings | -CN¥912.86k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0012 |
| Gross Margin | 30.78% |
| Net Profit Margin | -0.043% |
| Debt/Equity Ratio | 0% |
How did 6127 perform over the long term?
See historical performance and comparison